Phase II study of mitomycin C, cisplatin and 5-fluorouracil for advanced and recurrent gastric cancer

Anticancer Research

Volumn 22, Issue 6 B, 2002, Pages 3633-3636

  Kikuyama, Shigehiro ^a   Inada, Takao ^b   Oyama, Renpei ^a   Ogata, Yoshiro ^b  

^a SAISEIKAI CENTRAL HOSPITAL   (Japan)

^b TOCHIGI CANCER CENTER   (Japan)

Author keywords

5 fluorouracil; Cisplatin; Clinical study; Gastric cancer; Mitomycin C

Indexed keywords

ANTIEMETIC AGENT; CISPLATIN; FLUOROURACIL; MITOMYCIN C;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DRUG EFFICACY; FEMALE; GASTRECTOMY; HUMAN; KIDNEY FAILURE; LEUKOPENIA; MALE; MUCOSA INFLAMMATION; NAUSEA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RECURRENT CANCER; STOMACH CARCINOMA; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; LEUKOPENIA; MALE; MIDDLE AGED; MITOMYCIN; NAUSEA; NEOPLASM RECURRENCE, LOCAL; STOMACH NEOPLASMS; VOMITING;

EID: 0036875570     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Macdonald JS, Woolley PV, Smythe T, Ueno W, Hoth D and Schein PS: 5-Fluorouracil, adriamycin, and mitomycin-C (FAM) combination chemotherapy in the treatment of advanced gastric cancer. Cancer 44: 42-27, 1979.
2. Findlay M, Cunningham D, Norman A, Mansi J, Nicolson M, Hicksh T, Nicolson V, Nash A, Sacks N and Ford H: A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF). Ann Oncol 5: 609-616, 1994.
3. Zaniboni A, Barni S, Labianca R, Marini G, Pancera G, Giaccon G, Piazza E, Signaroldi A, Legnani W and Luporini G: Epirubicin, cisplatin, and continuous infusion 5-fluorouracil is an active and safe regimen for patients with advanced gastric cancer. Cancer 76: 1694-1699, 1995.
4. Kurihara M, Kubota T, Hoshiya Y, Otani Y, Watanabe M and Kumai K: Antitumor activity of cis-diaminedichloroplatinum (II) against human tumor xenografts depends on its area under the curve in nude mice. J Surg Oncol 61: 138-142, 1996.
5. Kurihara N, Kubota T, Hoshiya Y, Otani Y, Ando N and Kumai K: Pharmacokinetics of cis-diaminedichloroplatinum (II) given as lowdose and high-dose infusions. J Surg Oncol 62: 135-138, 1996.
6. World Health Organization: WHO Handbook for Reporting Results of Cancer Treatment. WHO Offset Publication No.48. Geneva: World Health Organizatin, 1979.
7. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma (The 13th Edition). Tokyo: Kanehara, 1999.
8. Kikuyama S, Inada T, Miyakita M and Ogata Y: Phase II study of 5-fluorouracil, piraraubicin and low-dose consecutive administration of cisplatin for advanced and recurrent gastric cancer. Jpn J Clin Oncol 28: 314-317, 1998.
9. Lacave AJ, Izarzugaza I, Anton Aparicio LM, Valle Pereda M, Gracia Marco JM and Buesa JM: Phase II clinical trial of cisdichlorodiammineplatinum in gastric cancer. Am J Clin Oncol 6: 35-38, 1983.
10. Cullian SA, Moertel CG, Fleming TR, Rubin JR, Krook JE, Everson LK, Windschitl HE, Twito DI, Marschke RF, Foley JF, Pfeifle DM and Barlow JF: A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic anc gastric carcinoma. JAMA 253: 2061-2067, 1985.
11. Lesesne JB, Rothschild N, Erickson B, Korec S, Sisk R, Keller J, Arbus M, Woolley PV, Chiazze L, Schein PS and Neefe JR: Cancer-associated hemolytic-uremic syndrome: Analysis of 85 cases from a national registry. J Clin Oncol 7: 781-789, 1989.
12. Webb A, Cunningham D, Scarffe JH, Harper P, Norman A, Joffe JK, Hughes M, Mansi J, Findlay M, Hill A, Oates J, Nicolson M, Hickish T, O'Brien M, Iveson T, Watson M, Underhill C, Wardley A and Meehan M: Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. J Clin Oncol 15: 261-267, 1997.
13. Ohtsu A, Shimada Y, Yoshida S, Saito H, Seki S, Morise K and Kurihara M: Phase II study of protracted infusional 5-fluorouracil combined with cisplatinum for advanced gastric cancer: Report from the Japan Clinical Oncology Group (JCOG). Eur J Cancer 30A: 2091-2093, 1994.